Immutep Limited (IMMP) Financials

IMMP Assets vs Liabilities
DateAssetsLiabilities
March 31, 2024 ? ?
Dec. 31, 2023 84.3 million 5.5 million
Sept. 30, 2023 94.8 million 7.1 million
June 30, 2023 97.8 million 7.3 million

IMMP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 -351459 ?
Dec. 31, 2023 -3.7 million 682804
Sept. 30, 2023 -8.5 million 1.3 million
June 30, 2023 -5.5 million 1.3 million

IMMP Net Income

No data available :(

IMMP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2024 - - -
Dec. 31, 2023 70.7 million 611755 345356
Sept. 30, 2023 79.3 million - -
June 30, 2023 81.9 million 691998 260609

IMMP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2024 ?
Dec. 31, 2023 815.4 million
Sept. 30, 2023 592.4 million
June 30, 2023 787.7 million

IMMP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2024 351459 - - -
Dec. 31, 2023 4769 13.9 million 16.5 million 13.2 million
Sept. 30, 2023 217264 6.3 million 2.9 million 10.5 million
June 30, 2023 1990 6.5 million 13.9 million 10.9 million

IMMP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2024 - -
Dec. 31, 2023 1.4 million 678430
Sept. 30, 2023 1.2 million 593955
June 30, 2023 1.2 million 613021

IMMP

Price: $0.36

52 week price:
0.29
3.53

Earnings Per Share: -0.40 USD

P/E Ratio: -6.82

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 112316

Market Capitalization: 55.5 million

Links: